Sanger Sequencing Market Report 2024: Strategies And Recent Developments | Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2193

The Business Research Company offers in-depth market insights through Sanger Sequencing Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.29 billion in 2023 to $2.75 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.30 billion in 2028 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

Market Segmentation:
The sanger sequencing market covered in this report is segmented -

1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory: Wet Labs, Dry Labs
3) By Research: In-House, Outsourced
4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

Major Driver - Genetic Illness Surge Fuels Sanger Sequencing Market Growth
The rise in genetic illness is expected to propel the growth of the sanger sequencing market going forward. A genetic illness, or genetic disorder, is a medical condition caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is used to diagnose genetic illnesses by determining the exact order of nucleotides (the building blocks of DNA) in a specific gene or region of DNA. For instance, in February 2024, according to the Genetic Rare Diseases Information Center (GARD, a US-based government agency, there were about 7,000 known rare genetic diseases, accounting for about 1 in 10 people, or 30 million people in the United States during 2020-2021. Therefore, the rise in genetic illness is driving the growth of the sanger sequencing market.

Competitive Landscape:
Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

Top Trend - Advancements In Sanger Sequencing Technology Drive Market Growth
Major companies operating in the sanger sequencing market are developing advanced sanger sequencing systems to drive revenues in the market. Advanced sanger sequencing systems are designed to handle higher throughput, allowing for the simultaneous processing of multiple samples. For instance, in October 2021, Promega Corporation, a US-based manufacturer of enzymes and other products, launched the ProDye Terminator Sequencing System, which is compatible with all capillary electrophoresis (CE) platforms, including the benchtop Spectrum Compact CE System. This system allows research labs to perform Sanger sequencing on any CE instrument, making it suitable for various laboratory sizes. The ProDye Terminator Sequencing System uses a proprietary thermostable DNA polymerase and can be implemented on instruments such as the Spectrum Compact CE System, SeqStudio Genetic Analyzers, and Applied Biosystems Genetic Analyzers.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Sanger Sequencing Market Characteristics
3. Sanger Sequencing Market Trends And Strategies
4. Sanger Sequencing Market - Macro Economic Scenario
5. Sanger Sequencing Market Size And Growth
…..
27. Sanger Sequencing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.